Drug Side Effects

SULFASALAZINE

SULFASALAZINE was reported 58842 times

SULFASALAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 65 0.9701
1 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 271 0.9218
2 SWOLLEN JOINT COUNT INCREASED 654 0.8720
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2906 0.8623
4 RED BLOOD CELL SEDIMENTATION RATE 196 0.8412
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 113 0.8129
6 RHEUMATOID FACTOR POSITIVE 2187 0.7121
7 RHEUMATIC FEVER 734 0.6834
8 PEMPHIGUS 4735 0.6723
9 LUPUS VULGARIS 47 0.6528
10 GRANULOMA SKIN 423 0.6409
11 DUODENAL ULCER PERFORATION 1847 0.6151
12 MUSCULOSKELETAL DEFORMITY 126 0.6000
13 HAND DEFORMITY 4337 0.5461
14 PRESBYACUSIS 147 0.5288
15 RHEUMATOID FACTOR NEGATIVE 88 0.5269
16 C-REACTIVE PROTEIN ABNORMAL 1817 0.5193
17 BODY HEIGHT BELOW NORMAL 286 0.4743
18 SYNOVITIS 5588 0.4625
19 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 880 0.4501
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 107 0.4332
21 BLOOD IRON ABNORMAL 296 0.4134
22 BLOOD PARATHYROID HORMONE DECREASED 503 0.4120
23 INTESTINAL SEPSIS 65 0.3824
24 ENTHESOPATHY 418 0.3699
25 DRUG TOLERANCE DECREASED 591 0.3685
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1208 0.3654
27 HELICOBACTER INFECTION 1896 0.3549
28 C-REACTIVE PROTEIN 58 0.3537
29 CONTRAINDICATED PRODUCT ADMINISTERED 7122 0.3511
30 SERONEGATIVE ARTHRITIS 182 0.3285
31 BONE EROSION 720 0.3114
32 PERICARDITIS 2955 0.3092
33 PANNICULITIS 529 0.2972
34 GLOSSODYNIA 4526 0.2906
35 CYTOLOGY ABNORMAL 36 0.2880
36 RHEUMATOID NODULE 633 0.2730
37 PLEURAL THICKENING 123 0.2703
38 RED CELL DISTRIBUTION WIDTH DECREASED 91 0.2661
39 MUSCLE INJURY 1093 0.2575
40 X-RAY ABNORMAL 179 0.2412
41 FOLLICULITIS 1119 0.2336
42 RETINITIS 136 0.2313
43 SYSTEMIC LUPUS ERYTHEMATOSUS 5111 0.2296
44 DISLOCATION OF VERTEBRA 176 0.2256
45 DACTYLITIS 141 0.2227
46 NECK DEFORMITY 86 0.2199
47 WOUND 3747 0.2022
48 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1650 0.1980
49 JOINT DESTRUCTION 236 0.1963
50 ANKLE ARTHROPLASTY 42 0.1953
51 JUVENILE IDIOPATHIC ARTHRITIS 327 0.1930
52 TENOSYNOVITIS 426 0.1910
53 WRIST DEFORMITY 98 0.1907
54 DISABILITY ASSESSMENT SCALE SCORE INCREASED 43 0.1814
55 RHEUMATOID ARTHRITIS 14820 0.1800
56 THERAPEUTIC PRODUCT EFFECT DECREASED 4615 0.1773
57 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 107 0.1712
58 TENOSYNOVITIS STENOSANS 74 0.1709
59 AXIAL SPONDYLOARTHRITIS 38 0.1704
60 NONALCOHOLIC FATTY LIVER DISEASE 34 0.1692
61 MEAN PLATELET VOLUME DECREASED 95 0.1684
62 PLEURAL FIBROSIS 157 0.1639
63 FACET JOINT SYNDROME 110 0.1634
64 BLOOD MAGNESIUM INCREASED 117 0.1634
65 ANTIBODY TEST POSITIVE 234 0.1614
66 VASCULAR ACCESS COMPLICATION 94 0.1567
67 ELBOW DEFORMITY 46 0.1544
68 DRUG INTOLERANCE 10530 0.1538
69 ARTHRODESIS 113 0.1400
70 ARTHROPATHY 5857 0.1393
71 POLYARTHRITIS 499 0.1384
72 SOFT TISSUE SWELLING 52 0.1372
73 ALANINE AMINOTRANSFERASE ABNORMAL 196 0.1348
74 TRANSPLANT DYSFUNCTION 179 0.1345
75 GRIP STRENGTH DECREASED 672 0.1335
76 DRUG SPECIFIC ANTIBODY 117 0.1257
77 BLOOD PRESSURE DIASTOLIC ABNORMAL 211 0.1237
78 BLOOD PRESSURE SYSTOLIC ABNORMAL 179 0.1233
79 RHEUMATOID LUNG 89 0.1168
80 INFLAMMATORY PAIN 51 0.1167
81 TREATMENT FAILURE 6433 0.1150
82 BONE CYST 89 0.1117
83 MYCOTIC ALLERGY 54 0.1111
84 SPONDYLOARTHROPATHY 47 0.1108
85 EXTREMITY CONTRACTURE 58 0.1068
86 SKIN NECROSIS 453 0.1053
87 PSORIATIC ARTHROPATHY 2482 0.1042
88 JOINT SWELLING 8875 0.1016
89 SYNOVIAL DISORDER 34 0.0991
90 BONE SWELLING 81 0.0990
91 C-REACTIVE PROTEIN DECREASED 49 0.0982
92 C-REACTIVE PROTEIN INCREASED 2561 0.0981
93 JOINT ANKYLOSIS 42 0.0974
94 APPARENT DEATH 340 0.0950
95 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2698 0.0937
96 MEAN CELL VOLUME DECREASED 108 0.0933
97 INFUSION RELATED REACTION 4156 0.0928
98 HIP ARTHROPLASTY 932 0.0922
99 IRRITABLE BOWEL SYNDROME 1337 0.0917
100 KNEE ARTHROPLASTY 1171 0.0869
101 DISCOMFORT 3463 0.0858
102 BLOODY DISCHARGE 76 0.0858
103 JOINT ARTHROPLASTY 119 0.0848
104 ONYCHOMYCOSIS 242 0.0844
105 MEAN CELL HAEMOGLOBIN DECREASED 109 0.0842
106 JOINT RANGE OF MOTION DECREASED 687 0.0813
107 HEPATIC ENZYME INCREASED 3945 0.0809
108 CLEAR CELL RENAL CELL CARCINOMA 40 0.0795
109 SWELLING 5379 0.0777
110 FINGER DEFORMITY 262 0.0775
111 ANKYLOSING SPONDYLITIS 576 0.0773
112 PERIPHERAL VENOUS DISEASE 120 0.0769
113 SCLERITIS 84 0.0755
114 FINE MOTOR SKILL DYSFUNCTION 147 0.0742
115 PEPTIC ULCER HAEMORRHAGE 40 0.0731
116 MUSCULOSKELETAL STIFFNESS 4737 0.0720
117 FOOT DEFORMITY 601 0.0719
118 DEATH NEONATAL 80 0.0712
119 SACROILIITIS 95 0.0709
120 OVARIAN NEOPLASM 43 0.0680
121 SPINAL STENOSIS 151 0.0676
122 JOINT EFFUSION 372 0.0674
123 WHEELCHAIR USER 228 0.0673
124 INFUSION SITE REACTION 103 0.0659
125 LYMPHADENECTOMY 47 0.0632
126 DEAFNESS NEUROSENSORY 153 0.0621
127 INTERNATIONAL NORMALISED RATIO FLUCTUATION 122 0.0620
128 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2414 0.0595
129 OSTEOSCLEROSIS 76 0.0591
130 IMPAIRED HEALING 1409 0.0581
131 LIVER INJURY 804 0.0579
132 LIMB DEFORMITY 78 0.0571
133 RHEUMATIC DISORDER 82 0.0561
134 HYPERCALCAEMIA 530 0.0560
135 PRERENAL FAILURE 59 0.0556
136 MATERNAL EXPOSURE DURING PREGNANCY 3134 0.0552
137 EXOSTOSIS 374 0.0549
138 LIVE BIRTH 281 0.0548
139 ONYCHOMADESIS 132 0.0546
140 FIBROMYALGIA 923 0.0541
141 INFLAMMATION 1875 0.0539
142 BASAL CELL CARCINOMA 635 0.0535
143 SYNOVIAL CYST 194 0.0526
144 OSTEOARTHRITIS 1665 0.0526
145 ABDOMINAL DISCOMFORT 6450 0.0524
146 PULMONARY TOXICITY 237 0.0521
147 WHITE BLOOD CELL COUNT ABNORMAL 239 0.0521
148 THYROID NEOPLASM 134 0.0520
149 RETINAL TOXICITY 40 0.0517
150 IMMOBILE 177 0.0516
151 LIVER FUNCTION TEST INCREASED 700 0.0516
152 DRUG ERUPTION 652 0.0510
153 BLADDER TRANSITIONAL CELL CARCINOMA 64 0.0508
154 DEFORMITY 404 0.0508
155 FEAR OF INJECTION 209 0.0504
156 LOWER RESPIRATORY TRACT INFECTION 1552 0.0502
157 SHOULDER ARTHROPLASTY 82 0.0500
158 NECK MASS 108 0.0500
159 TUBERCULIN TEST POSITIVE 117 0.0496
160 NAIL DISORDER 286 0.0496
161 EPIGASTRIC DISCOMFORT 153 0.0495
162 MONOCYTE COUNT INCREASED 128 0.0494
163 MACROCYTOSIS 47 0.0494
164 JOINT STIFFNESS 979 0.0493
165 ALLERGY TO CHEMICALS 43 0.0493
166 HEPATIC ENZYME ABNORMAL 181 0.0492
167 INVESTIGATION ABNORMAL 38 0.0488
168 BREAST CANCER STAGE III 205 0.0488
169 STRESS AT WORK 36 0.0472
170 ADRENAL INSUFFICIENCY 344 0.0468
171 PULMONARY FIBROSIS 626 0.0466
172 CUSHINGOID 108 0.0466
173 PRURITUS ALLERGIC 40 0.0462
174 SCIATICA 488 0.0461
175 BURSITIS 357 0.0459
176 TENDERNESS 375 0.0451
177 GASTROINTESTINAL TOXICITY 134 0.0449
178 NODULE 429 0.0444
179 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 144 0.0442
180 CREPITATIONS 113 0.0442
181 COLITIS MICROSCOPIC 130 0.0428
182 SMEAR CERVIX ABNORMAL 55 0.0427
183 MATERNAL EXPOSURE TIMING UNSPECIFIED 105 0.0426
184 MOBILITY DECREASED 2245 0.0424
185 BLISTER 1741 0.0423
186 SKIN ULCER 823 0.0411
187 DISABILITY 628 0.0411
188 ULCER 505 0.0409
189 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 53 0.0408
190 OBESITY 455 0.0398
191 ALOPECIA 6186 0.0398
192 TONGUE DISORDER 247 0.0398
193 DIVERTICULITIS 829 0.0397
194 ANTINUCLEAR ANTIBODY POSITIVE 108 0.0393
195 STOMATITIS 1744 0.0393
196 PLEURITIC PAIN 90 0.0391
197 HEPATOTOXICITY 620 0.0386
198 DRUG TOLERANCE 151 0.0385
199 INFLAMMATORY MARKER INCREASED 116 0.0384
200 EPICONDYLITIS 47 0.0383
201 ILL-DEFINED DISORDER 1205 0.0381
202 JOINT DISLOCATION 295 0.0375
203 DRUG HYPERSENSITIVITY 5811 0.0374
204 PHYSICAL DISABILITY 142 0.0371
205 GASTROINTESTINAL DISORDER 2062 0.0368
206 PERIPHERAL SWELLING 3971 0.0366
207 GRANULOMA 97 0.0365
208 BLOOD PRESSURE DIASTOLIC INCREASED 114 0.0364
209 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 65 0.0364
210 PUSTULAR PSORIASIS 93 0.0362
211 ARTHRITIS 2111 0.0360
212 BLOOD CHOLESTEROL INCREASED 1254 0.0357
213 ARTHRITIS BACTERIAL 112 0.0357
214 BONE DENSITY ABNORMAL 111 0.0354
215 LATENT TUBERCULOSIS 51 0.0351
216 COELIAC DISEASE 255 0.0350
217 TYPE 2 DIABETES MELLITUS 908 0.0348
218 EFFUSION 38 0.0348
219 WOUND INFECTION 233 0.0342
220 PRECANCEROUS CELLS PRESENT 41 0.0336
221 MUSCULOSKELETAL PAIN 1561 0.0334
222 FOOD INTOLERANCE 86 0.0330
223 LUPUS-LIKE SYNDROME 211 0.0329
224 TERMINAL STATE 171 0.0325
225 NEOPLASM SKIN 37 0.0323
226 HYPERSENSITIVITY 4585 0.0323
227 LYME DISEASE 80 0.0321
228 WALKING AID USER 150 0.0319
229 INFECTION 3275 0.0319
230 UVEITIS 276 0.0319
231 THERAPY NON-RESPONDER 838 0.0317
232 PULMONARY THROMBOSIS 255 0.0315
233 INTENTIONAL PRODUCT USE ISSUE 1783 0.0315
234 ARTHRALGIA 9299 0.0315
235 HYPERCHOLESTEROLAEMIA 198 0.0315
236 BLOOD PRESSURE SYSTOLIC INCREASED 443 0.0310
237 KNEE DEFORMITY 35 0.0309
238 MUSCULOSKELETAL DISORDER 475 0.0308
239 TRANSPLANT REJECTION 179 0.0305
240 BLOOD PRESSURE DIASTOLIC DECREASED 168 0.0303
241 INTERSTITIAL LUNG DISEASE 1067 0.0303
242 BLOOD PRESSURE FLUCTUATION 571 0.0303
243 COSTOCHONDRITIS 39 0.0301
244 GAIT INABILITY 579 0.0300
245 CONDITION AGGRAVATED 5980 0.0296
246 DERMATITIS ALLERGIC 256 0.0296
247 DEMYELINATION 94 0.0289
248 SENSITIVITY TO WEATHER CHANGE 98 0.0286
249 PRODUCT USE ISSUE 3800 0.0284
250 OVARIAN CYST 239 0.0282
251 BRONCHIECTASIS 125 0.0281
252 JOINT INJURY 452 0.0280
253 SPONDYLITIS 67 0.0279
254 TENDONITIS 351 0.0278
255 RENAL MASS 44 0.0274
256 HEPATITIS 541 0.0274
257 OSTEOPOROTIC FRACTURE 37 0.0270
258 HEPATIC CIRRHOSIS 366 0.0269
259 SINUSITIS 2032 0.0265
260 TONGUE ULCERATION 71 0.0262
261 CYST 247 0.0261
262 GENERAL PHYSICAL HEALTH DETERIORATION 2033 0.0259
263 LIP DRY 130 0.0258
264 ARTHRITIS INFECTIVE 88 0.0257
265 RED CELL DISTRIBUTION WIDTH INCREASED 73 0.0255
266 PULMONARY MASS 273 0.0253
267 IMPAIRED WORK ABILITY 447 0.0252
268 TUBERCULOSIS 244 0.0251
269 IRITIS 59 0.0250
270 SPINAL FUSION SURGERY 68 0.0249
271 AUTOIMMUNE DISORDER 131 0.0248
272 PYODERMA GANGRENOSUM 54 0.0247
273 BODY TEMPERATURE DECREASED 196 0.0244
274 BACK INJURY 183 0.0244
275 ONYCHOCLASIS 120 0.0242
276 DRUG INEFFECTIVE 23841 0.0242
277 CARPAL TUNNEL SYNDROME 259 0.0241
278 PAIN 11366 0.0237
279 PULMONARY TUBERCULOSIS 81 0.0233
280 FOOT OPERATION 78 0.0233
281 MULTIPLE ALLERGIES 124 0.0229
282 OSTEOPENIA 279 0.0229
283 HYPERSENSITIVITY VASCULITIS 57 0.0228
284 MICROCYTIC ANAEMIA 38 0.0228
285 THERAPEUTIC RESPONSE DECREASED 1002 0.0227
286 PRESCRIBED OVERDOSE 329 0.0225
287 IMMUNODEFICIENCY 203 0.0223
288 DERMATOMYOSITIS 39 0.0223
289 RASH 6971 0.0222
290 HEPATIC FIBROSIS 56 0.0219
291 LYMPHOPROLIFERATIVE DISORDER 46 0.0215
292 NECK PAIN 903 0.0212
293 LOWER LIMB FRACTURE 279 0.0210
294 LYMPHOMA 254 0.0210
295 LIVER FUNCTION TEST ABNORMAL 536 0.0209
296 LOCALISED INFECTION 381 0.0209
297 JOINT LOCK 46 0.0209
298 CANDIDA INFECTION 241 0.0209
299 ADVERSE REACTION 213 0.0208
300 NASOPHARYNGITIS 2702 0.0208
301 OSTEOPOROSIS 679 0.0208
302 ORAL DISCOMFORT 226 0.0206
303 DRUG-INDUCED LIVER INJURY 377 0.0205
304 BONE LESION 57 0.0204
305 CONTUSION 1488 0.0204
306 ENDODONTIC PROCEDURE 40 0.0203
307 HERPES ZOSTER 888 0.0202
308 PERIARTHRITIS 35 0.0201
309 DRUG EFFECT INCOMPLETE 727 0.0199
310 SPINAL PAIN 169 0.0197
311 PNEUMOCYSTIS JIROVECI PNEUMONIA 44 0.0197
312 MOUTH ULCERATION 300 0.0195
313 LUNG DISORDER 703 0.0195
314 EXPOSURE DURING PREGNANCY 874 0.0195
315 MATERNAL EXPOSURE BEFORE PREGNANCY 85 0.0195
316 PRESCRIBED UNDERDOSE 269 0.0191
317 IRON DEFICIENCY 56 0.0190
318 WEIGHT BEARING DIFFICULTY 40 0.0189
319 ALANINE AMINOTRANSFERASE INCREASED 930 0.0189
320 MENISCUS INJURY 88 0.0188
321 PHOTOSENSITIVITY REACTION 240 0.0187
322 ANAL FISSURE 60 0.0186
323 UTERINE DISORDER 37 0.0186
324 MUSCULOSKELETAL DISCOMFORT 239 0.0184
325 LARYNGITIS 143 0.0183
326 RASH PRURITIC 704 0.0179
327 INCORRECT DOSAGE ADMINISTERED 63 0.0179
328 LIVER DISORDER 590 0.0179
329 THERAPY PARTIAL RESPONDER 91 0.0179
330 HEPATIC STEATOSIS 253 0.0179
331 ATRIOVENTRICULAR BLOCK COMPLETE 92 0.0178
332 POOR VENOUS ACCESS 117 0.0178
333 ASPARTATE AMINOTRANSFERASE INCREASED 755 0.0177
334 PRODUCT LABEL CONFUSION 65 0.0177
335 GOITRE 60 0.0176
336 ERYTHEMA NODOSUM 43 0.0174
337 COLITIS ULCERATIVE 461 0.0174
338 ROTATOR CUFF SYNDROME 179 0.0173
339 SLEEP DISORDER 850 0.0173
340 PYELONEPHRITIS 111 0.0171
341 THERAPEUTIC RESPONSE SHORTENED 199 0.0170
342 ADVERSE DRUG REACTION 1008 0.0169
343 LYMPHOCYTE COUNT INCREASED 39 0.0166
344 MUSCLE FATIGUE 51 0.0166
345 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 156 0.0166
346 ANAPHYLACTIC REACTION 639 0.0166
347 FOOT FRACTURE 246 0.0164
348 ORAL CANDIDIASIS 154 0.0163
349 GASTRIC DISORDER 528 0.0162
350 THROMBOCYTOSIS 43 0.0162
351 LIMB DISCOMFORT 376 0.0162
352 HEPATIC CYST 43 0.0162
353 SHOULDER OPERATION 41 0.0162
354 PLATELET COUNT INCREASED 157 0.0161
355 VASCULITIS 136 0.0161
356 SPINAL OSTEOARTHRITIS 114 0.0161
357 THYROID DISORDER 184 0.0160
358 PAIN IN EXTREMITY 3724 0.0159
359 CHRONIC SINUSITIS 41 0.0159
360 ANAL HAEMORRHAGE 34 0.0159
361 MALIGNANT MELANOMA 166 0.0158
362 SPUTUM DISCOLOURED 108 0.0157
363 TOOTH INFECTION 153 0.0156
364 FATIGUE 8894 0.0155
365 ATELECTASIS 122 0.0153
366 THERAPEUTIC PRODUCT EFFECT DELAYED 35 0.0152
367 GROIN PAIN 106 0.0151
368 SARCOIDOSIS 54 0.0150
369 DRY EYE 426 0.0148
370 SKIN LACERATION 101 0.0147
371 ORGANISING PNEUMONIA 49 0.0147
372 BEDRIDDEN 151 0.0147
373 OSTEOMYELITIS 220 0.0147
374 SKIN LESION 292 0.0146
375 SKIN REACTION 156 0.0146
376 MENINGITIS 74 0.0145
377 PREGNANCY 257 0.0145
378 DRUG SPECIFIC ANTIBODY PRESENT 59 0.0144
379 LIGAMENT SPRAIN 103 0.0144
380 GLAUCOMA 214 0.0143
381 TOOTH ABSCESS 119 0.0142
382 SEPTIC SHOCK 447 0.0141
383 HYPERTENSION 2250 0.0140
384 GAIT DISTURBANCE 2105 0.0140
385 BONE DENSITY DECREASED 381 0.0139
386 IMPAIRED GASTRIC EMPTYING 80 0.0139
387 NIGHT SWEATS 322 0.0138
388 INJECTION SITE INFLAMMATION 49 0.0138
389 ADVERSE EVENT 985 0.0138
390 PSORIASIS 1314 0.0137
391 WHEEZING 560 0.0137
392 IMMUNOSUPPRESSION 77 0.0136
393 TRIGGER FINGER 39 0.0136
394 HYPOGAMMAGLOBULINAEMIA 49 0.0135
395 OEDEMA 548 0.0134
396 THROAT CANCER 49 0.0134
397 FLANK PAIN 97 0.0134
398 MUSCLE STRAIN 89 0.0133
399 ESCHERICHIA URINARY TRACT INFECTION 44 0.0132
400 HIP SURGERY 43 0.0131
401 GASTROINTESTINAL PAIN 102 0.0130
402 BREAST MASS 68 0.0129
403 PURULENT DISCHARGE 45 0.0129
404 ORAL HERPES 174 0.0129
405 LYMPHADENOPATHY 343 0.0127
406 NEOPLASM MALIGNANT 624 0.0127
407 GASTRIC INFECTION 35 0.0127
408 HEART RATE DECREASED 348 0.0127
409 SKIN INFECTION 100 0.0126
410 SWELLING OF EYELID 37 0.0126
411 WEIGHT INCREASED 2120 0.0126
412 VARICOSE VEIN 51 0.0126
413 STRESS 655 0.0125
414 ANKLE FRACTURE 151 0.0125
415 EYE DISORDER 305 0.0125
416 CONJUNCTIVITIS 149 0.0124
417 HAEMATOCRIT DECREASED 206 0.0123
418 BREATH SOUNDS ABNORMAL 43 0.0123
419 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 215 0.0122
420 LEUKOPENIA 461 0.0122
421 APHTHOUS ULCER 56 0.0122
422 CATARACT 516 0.0122
423 OFF LABEL USE 6246 0.0121
424 INTERVERTEBRAL DISC DEGENERATION 95 0.0121
425 DIFFUSE LARGE B-CELL LYMPHOMA 55 0.0121
426 NEPHROLITHIASIS 401 0.0121
427 DIARRHOEA HAEMORRHAGIC 87 0.0121
428 IMPAIRED QUALITY OF LIFE 101 0.0120
429 HIDRADENITIS 41 0.0120
430 AFFECTIVE DISORDER 69 0.0119
431 SPINAL COLUMN STENOSIS 56 0.0118
432 BLOOD ALBUMIN DECREASED 74 0.0118
433 BRONCHITIS 695 0.0117
434 HAEMORRHAGIC DIATHESIS 34 0.0117
435 INJURY 701 0.0117
436 RASH VESICULAR 39 0.0116
437 ORAL INFECTION 35 0.0115
438 DRUG EFFECT DECREASED 622 0.0115
439 HERNIA 161 0.0115
440 RED BLOOD CELL COUNT DECREASED 246 0.0114
441 EAR INFECTION 206 0.0114
442 DYSPEPSIA 835 0.0114
443 GASTROENTERITIS VIRAL 146 0.0114
444 OXYGEN SATURATION DECREASED 435 0.0113
445 NERVE COMPRESSION 78 0.0113
446 EYE INFECTION 87 0.0113
447 SPINAL DISORDER 83 0.0113
448 SKIN PLAQUE 66 0.0112
449 PNEUMONITIS 207 0.0111
450 FEEDING DISORDER 136 0.0110
451 ABSCESS 131 0.0110
452 SQUAMOUS CELL CARCINOMA 81 0.0110
453 INJECTION SITE IRRITATION 108 0.0110
454 INJECTION SITE REACTION 584 0.0110
455 SINUS HEADACHE 55 0.0110
456 PELVIC FRACTURE 65 0.0109
457 EAR PAIN 161 0.0109
458 UROSEPSIS 76 0.0109
459 PHOTOPHOBIA 148 0.0109
460 POSTOPERATIVE WOUND INFECTION 53 0.0108
461 BLOOD IRON DECREASED 85 0.0108
462 LYMPHOEDEMA 54 0.0107
463 POST PROCEDURAL INFECTION 61 0.0107
464 TONSILLITIS 41 0.0107
465 FREQUENT BOWEL MOVEMENTS 184 0.0106
466 DEEP VEIN THROMBOSIS 589 0.0105
467 VITAMIN D DECREASED 71 0.0105
468 PAIN IN JAW 240 0.0104
469 PNEUMONIA 2481 0.0104
470 PRODUCTIVE COUGH 337 0.0103
471 RESPIRATORY TRACT CONGESTION 119 0.0103
472 CONFUSIONAL STATE 1314 0.0103
473 BLOOD PRESSURE SYSTOLIC DECREASED 35 0.0102
474 ROSACEA 34 0.0102
475 RENAL CYST 66 0.0102
476 SECRETION DISCHARGE 83 0.0101
477 DYSSTASIA 233 0.0101
478 PRE-EXISTING CONDITION IMPROVED 57 0.0101
479 BLOOD POTASSIUM INCREASED 129 0.0101
480 MOVEMENT DISORDER 255 0.0100
481 DECREASED IMMUNE RESPONSIVENESS 62 0.0100
482 LARGE INTESTINE POLYP 54 0.0100
483 PYREXIA 2658 0.0100
484 PNEUMONIA BACTERIAL 58 0.0099
485 INFLUENZA 742 0.0099
486 LABORATORY TEST ABNORMAL 217 0.0098
487 MASS 108 0.0097
488 INTESTINAL PERFORATION 83 0.0096
489 SCRATCH 61 0.0096
490 NAUSEA 5716 0.0095
491 RESPIRATORY TRACT INFECTION 171 0.0095
492 PRURITUS 2386 0.0095
493 PHARYNGITIS 93 0.0095
494 BLOOD CREATININE INCREASED 493 0.0095
495 PERIPHERAL VASCULAR DISORDER 43 0.0094
496 TENDON DISORDER 49 0.0094
497 TENDON RUPTURE 96 0.0094
498 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 62 0.0094
499 STENT PLACEMENT 62 0.0094
500 BLOOD TEST ABNORMAL 91 0.0093
501 UPPER RESPIRATORY TRACT INFECTION 317 0.0093
502 DYSLIPIDAEMIA 35 0.0093
503 TRANSAMINASES INCREASED 164 0.0093
504 GENERALISED ERYTHEMA 53 0.0093
505 ANAL ABSCESS 34 0.0092
506 OROPHARYNGEAL PAIN 627 0.0092
507 FUNGAL INFECTION 230 0.0092
508 THROMBOSIS 585 0.0092
509 INGUINAL HERNIA 44 0.0091
510 TOE AMPUTATION 40 0.0091
511 BACK PAIN 1637 0.0091
512 SPINAL COMPRESSION FRACTURE 65 0.0091
513 VISUAL IMPAIRMENT 797 0.0090
514 PNEUMOCYSTIS JIROVECII PNEUMONIA 60 0.0090
515 DERMATITIS 128 0.0090
516 DRUG USE DISORDER 34 0.0090
517 VEIN DISORDER 36 0.0089
518 URTICARIA 1091 0.0089
519 SKIN WARM 40 0.0089
520 HEPATITIS B 44 0.0089
521 BACK DISORDER 110 0.0088
522 CROHN'S DISEASE 60 0.0087
523 DIVERTICULUM 57 0.0087
524 MUCOSAL INFLAMMATION 172 0.0087
525 INTERVERTEBRAL DISC PROTRUSION 154 0.0087
526 ILLNESS 299 0.0087
527 HEADACHE 4178 0.0086
528 UPPER-AIRWAY COUGH SYNDROME 49 0.0086
529 INFLAMMATORY BOWEL DISEASE 69 0.0086
530 CELLULITIS 344 0.0086
531 HAEMOLYTIC ANAEMIA 62 0.0086
532 INCREASED UPPER AIRWAY SECRETION 39 0.0085
533 SPLENOMEGALY 78 0.0085
534 MALAISE 2963 0.0085
535 NEPHROTIC SYNDROME 44 0.0085
536 PLEURISY 42 0.0083
537 CLOSTRIDIUM DIFFICILE INFECTION 127 0.0083
538 VOMITING 2944 0.0083
539 POLYP 42 0.0083
540 INFUSION SITE EXTRAVASATION 39 0.0083
541 CYSTITIS 212 0.0083
542 RESPIRATORY DISORDER 190 0.0083
543 SINUS CONGESTION 85 0.0083
544 PHARYNGOLARYNGEAL PAIN 44 0.0083
545 RHINORRHOEA 379 0.0082
546 MOTOR DYSFUNCTION 64 0.0082
547 INJECTION SITE HAEMATOMA 112 0.0082
548 HAEMATOCHEZIA 320 0.0082
549 CATARACT OPERATION 37 0.0081
550 MUSCULOSKELETAL CHEST PAIN 96 0.0081
551 QUALITY OF LIFE DECREASED 84 0.0081
552 BLOOD PRESSURE INCREASED 950 0.0081
553 DIARRHOEA 3789 0.0081
554 GASTROENTERITIS 91 0.0081
555 ORAL PAIN 142 0.0080
556 ENCEPHALITIS 40 0.0080
557 HYPOTHYROIDISM 181 0.0080
558 FURUNCLE 49 0.0079
559 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 688 0.0079
560 MIGRAINE 540 0.0079
561 FRACTURE 119 0.0079
562 PHARYNGITIS STREPTOCOCCAL 58 0.0079
563 SEPSIS 682 0.0079
564 SKIN FISSURES 82 0.0079
565 RALES 36 0.0079
566 HYPOAESTHESIA 920 0.0079
567 HERPES VIRUS INFECTION 35 0.0079
568 DELIRIUM 199 0.0079
569 AGRANULOCYTOSIS 100 0.0078
570 BLOOD PRESSURE ABNORMAL 108 0.0078
571 HYPOKINESIA 91 0.0078
572 SPINAL OPERATION 53 0.0078
573 ROAD TRAFFIC ACCIDENT 251 0.0078
574 ABDOMINAL PAIN UPPER 1193 0.0077
575 ECZEMA 162 0.0077
576 ORAL DISORDER 44 0.0077
577 WHITE BLOOD CELL COUNT INCREASED 237 0.0077
578 DRUG RESISTANCE 141 0.0076
579 NEUTROPENIC SEPSIS 44 0.0076
580 GASTRIC ULCER 118 0.0076
581 LIMB INJURY 147 0.0076
582 TOOTHACHE 106 0.0076
583 FISTULA 61 0.0076
584 SCOLIOSIS 37 0.0076
585 PHARYNGEAL SWELLING 38 0.0076
586 DRY MOUTH 462 0.0076
587 PULMONARY EMBOLISM 601 0.0076
588 LARGE INTESTINE PERFORATION 41 0.0075
589 HYPOCALCAEMIA 107 0.0075
590 RESPIRATORY RATE INCREASED 51 0.0075
591 HAEMOGLOBIN DECREASED 607 0.0075
592 DIABETES MELLITUS 464 0.0075
593 EMPHYSEMA 62 0.0075
594 RHINITIS 45 0.0075
595 NASAL CONGESTION 304 0.0075
596 COUGH 1494 0.0074
597 WEIGHT DECREASED 1570 0.0074
598 SEASONAL ALLERGY 66 0.0074
599 BODY TEMPERATURE INCREASED 122 0.0074
600 IMMUNE SYSTEM DISORDER 71 0.0073
601 FEELING JITTERY 116 0.0073
602 WRIST FRACTURE 68 0.0073
603 CYTOPENIA 48 0.0073
604 TOOTH LOSS 125 0.0073
605 SKIN DISORDER 170 0.0073
606 ABDOMINAL PAIN 1286 0.0073
607 PRODUCT USE IN UNAPPROVED INDICATION 1059 0.0072
608 COLITIS 186 0.0072
609 RASH MACULO-PAPULAR 118 0.0072
610 AFFECT LABILITY 59 0.0072
611 VITAMIN D DEFICIENCY 53 0.0072
612 VIRAL INFECTION 168 0.0071
613 GASTROINTESTINAL INFECTION 46 0.0071
614 BLOOD DISORDER 44 0.0071
615 NEUROPATHY PERIPHERAL 475 0.0071
616 PNEUMOTHORAX 84 0.0071
617 ARTHROPOD BITE 39 0.0071
618 RENAL IMPAIRMENT 433 0.0070
619 TOOTH DISORDER 126 0.0070
620 ERYTHEMA 1107 0.0070
621 FACIAL PARALYSIS 42 0.0070
622 FRUSTRATION TOLERANCE DECREASED 38 0.0070
623 BONE DISORDER 109 0.0070
624 INSOMNIA 1473 0.0070
625 WEIGHT FLUCTUATION 49 0.0069
626 HEPATITIS ACUTE 35 0.0069
627 LUNG INFECTION 108 0.0069
628 SKIN CANCER 111 0.0069
629 HEART RATE INCREASED 520 0.0069
630 INJECTION SITE PRURITUS 339 0.0068
631 IRON DEFICIENCY ANAEMIA 48 0.0068
632 GASTRIC HAEMORRHAGE 67 0.0067
633 COLON CANCER 79 0.0067
634 RECTAL HAEMORRHAGE 232 0.0067
635 MACULAR DEGENERATION 60 0.0067
636 TOOTH FRACTURE 59 0.0067
637 DRUG LEVEL DECREASED 46 0.0067
638 UPPER LIMB FRACTURE 110 0.0067
639 PANCREATITIS 280 0.0067
640 HYSTERECTOMY 42 0.0067
641 HYPERTENSIVE CRISIS 59 0.0066
642 INFLUENZA LIKE ILLNESS 444 0.0065
643 GASTROINTESTINAL INFLAMMATION 36 0.0065
644 HAND FRACTURE 35 0.0065
645 PROTEINURIA 86 0.0065
646 HAEMORRHOIDS 99 0.0064
647 MEDICATION ERROR 279 0.0064
648 POOR QUALITY SLEEP 99 0.0064
649 PANCYTOPENIA 264 0.0063
650 HEART RATE IRREGULAR 120 0.0063
651 PLEURAL EFFUSION 305 0.0063
652 DYSPNOEA 2739 0.0063
653 STAPHYLOCOCCAL INFECTION 170 0.0063
654 RASH ERYTHEMATOUS 198 0.0063
655 RIB FRACTURE 99 0.0063
656 RENAL FAILURE 712 0.0063
657 BRONCHOSPASM 72 0.0062
658 URINARY TRACT INFECTION 780 0.0062
659 MULTIPLE FRACTURES 87 0.0062
660 DISEASE RECURRENCE 166 0.0062
661 BODY HEIGHT DECREASED 59 0.0062
662 SCAR 85 0.0062
663 RENAL DISORDER 223 0.0062
664 HIATUS HERNIA 66 0.0062
665 BACTERIAL INFECTION 81 0.0061
666 POLYNEUROPATHY 51 0.0061
667 KIDNEY INFECTION 89 0.0061
668 INTESTINAL OBSTRUCTION 161 0.0060
669 TEMPERATURE INTOLERANCE 44 0.0060
670 OEDEMA PERIPHERAL 612 0.0060
671 HEPATOMEGALY 49 0.0060
672 CONCUSSION 34 0.0059
673 CHOLECYSTECTOMY 51 0.0059
674 SNEEZING 93 0.0059
675 GASTROOESOPHAGEAL REFLUX DISEASE 357 0.0059
676 ASTHMA 433 0.0059
677 DECREASED APPETITE 989 0.0059
678 GASTRITIS 122 0.0059
679 UTERINE LEIOMYOMA 34 0.0058
680 CHEST PAIN 862 0.0058
681 SWELLING FACE 292 0.0058
682 DYSPHONIA 252 0.0058
683 INJECTION SITE SWELLING 309 0.0057
684 ACCIDENT 50 0.0057
685 NERVE INJURY 51 0.0057
686 MOOD SWINGS 152 0.0057
687 TOXIC EPIDERMAL NECROLYSIS 64 0.0057
688 BURNING SENSATION 314 0.0057
689 NEURALGIA 100 0.0056
690 SCAB 47 0.0056
691 COVID-19 PNEUMONIA 40 0.0056
692 TREATMENT NONCOMPLIANCE 209 0.0056
693 SKIN DISCOLOURATION 200 0.0056
694 WHITE BLOOD CELL COUNT DECREASED 452 0.0056
695 LOSS OF CONSCIOUSNESS 560 0.0055
696 MUSCULAR WEAKNESS 481 0.0055
697 FEELING HOT 253 0.0055
698 SENSORY LOSS 35 0.0054
699 THYROID CANCER 57 0.0054
700 APHONIA 54 0.0054
701 INJECTION SITE BRUISING 308 0.0054
702 EMBOLISM 36 0.0054
703 CHILLS 483 0.0054
704 HEPATIC FUNCTION ABNORMAL 143 0.0053
705 AMNESIA 283 0.0053
706 PETECHIAE 43 0.0053
707 DEPRESSION 995 0.0053
708 FALL 1349 0.0053
709 BLOOD LACTATE DEHYDROGENASE INCREASED 70 0.0052
710 DISSEMINATED INTRAVASCULAR COAGULATION 61 0.0052
711 GENERALISED OEDEMA 48 0.0052
712 POST PROCEDURAL COMPLICATION 80 0.0052
713 INJECTION SITE RASH 108 0.0052
714 TOXIC SKIN ERUPTION 40 0.0051
715 INJECTION SITE PAIN 1071 0.0051
716 PRODUCT PRESCRIBING ERROR 70 0.0051
717 ACNE 320 0.0051
718 LOCAL SWELLING 89 0.0051
719 FEMUR FRACTURE 133 0.0051
720 STEVENS-JOHNSON SYNDROME 93 0.0051
721 PROCEDURAL PAIN 101 0.0051
722 INJECTION SITE ERYTHEMA 476 0.0050
723 PURPURA 36 0.0050
724 OESOPHAGITIS 43 0.0050
725 INTENTIONAL DOSE OMISSION 46 0.0050
726 INTRAOCULAR PRESSURE INCREASED 52 0.0050
727 BREAST CANCER 426 0.0050
728 DIZZINESS 1908 0.0050
729 INJECTION SITE URTICARIA 82 0.0050
730 MYELOSUPPRESSION 41 0.0049
731 PHARYNGEAL OEDEMA 74 0.0049
732 ASTHENIA 1406 0.0049
733 OCULAR HYPERAEMIA 156 0.0049
734 SARS-COV-2 TEST POSITIVE 40 0.0049
735 EJECTION FRACTION DECREASED 58 0.0049
736 SMALL INTESTINAL OBSTRUCTION 45 0.0048
737 BLOOD URINE PRESENT 74 0.0048
738 MITRAL VALVE INCOMPETENCE 44 0.0048
739 FACE OEDEMA 65 0.0048
740 CRYING 148 0.0048
741 CORONARY ARTERY OCCLUSION 57 0.0048
742 MYOCARDIAL ISCHAEMIA 48 0.0048
743 PRODUCT ODOUR ABNORMAL 34 0.0048
744 INJECTION SITE WARMTH 82 0.0047
745 PALPITATIONS 428 0.0047
746 SINUS DISORDER 70 0.0047
747 NEUTROPHIL COUNT INCREASED 38 0.0047
748 CHOLELITHIASIS 123 0.0047
749 ACTIVITIES OF DAILY LIVING IMPAIRED 93 0.0047
750 BLOOD ALKALINE PHOSPHATASE INCREASED 98 0.0047
751 DYSPNOEA EXERTIONAL 126 0.0047
752 SPINAL FRACTURE 68 0.0046
753 FEELING ABNORMAL 898 0.0046
754 EOSINOPHILIA 59 0.0046
755 MUSCLE TIGHTNESS 59 0.0046
756 INJECTION SITE EXTRAVASATION 53 0.0045
757 CARDIOVASCULAR DISORDER 103 0.0045
758 LEUKOCYTOSIS 63 0.0045
759 SLEEP APNOEA SYNDROME 71 0.0045
760 INJECTION SITE DISCOLOURATION 42 0.0045
761 MUSCLE SPASTICITY 47 0.0045
762 EMOTIONAL DISORDER 114 0.0045
763 GLOMERULAR FILTRATION RATE DECREASED 35 0.0045
764 CARDIOMEGALY 48 0.0045
765 PARAESTHESIA 535 0.0044
766 GALLBLADDER DISORDER 65 0.0044
767 LUNG INFILTRATION 34 0.0043
768 VERTIGO 208 0.0043
769 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0043
770 CARDIOMYOPATHY 51 0.0043
771 LIP SWELLING 109 0.0042
772 CHOLECYSTITIS 39 0.0042
773 ANAPHYLACTIC SHOCK 78 0.0042
774 SYNCOPE 332 0.0042
775 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 171 0.0042
776 UNEVALUABLE EVENT 257 0.0042
777 HYPOKALAEMIA 142 0.0041
778 LYMPHOCYTE COUNT DECREASED 55 0.0041
779 GAMMA-GLUTAMYLTRANSFERASE INCREASED 76 0.0041
780 ABDOMINAL DISTENSION 316 0.0041
781 FEELING COLD 88 0.0040
782 PRODUCT DISPENSING ERROR 48 0.0040
783 EYE PAIN 153 0.0040
784 ILEUS 37 0.0040
785 HEAD DISCOMFORT 50 0.0040
786 EATING DISORDER 66 0.0040
787 INJECTION SITE INDURATION 42 0.0039
788 ANGIOEDEMA 132 0.0039
789 TUBULOINTERSTITIAL NEPHRITIS 55 0.0039
790 MUSCLE SPASMS 557 0.0039
791 INJECTION SITE HAEMORRHAGE 220 0.0039
792 MYOCARDIAL INFARCTION 598 0.0039
793 LACERATION 36 0.0038
794 HEPATITIS C 42 0.0038
795 GOUT 52 0.0038
796 PRESYNCOPE 70 0.0038
797 ANGINA PECTORIS 92 0.0038
798 PULMONARY OEDEMA 134 0.0038
799 PERICARDIAL EFFUSION 65 0.0038
800 LUNG NEOPLASM MALIGNANT 131 0.0038
801 NEUTROPENIA 357 0.0038
802 HAEMOPTYSIS 83 0.0037
803 FAECES DISCOLOURED 64 0.0037
804 MYALGIA 490 0.0037
805 EYE PRURITUS 75 0.0037
806 HYPERLIPIDAEMIA 37 0.0037
807 HYPERHIDROSIS 372 0.0037
808 HYPOACUSIS 109 0.0037
809 HEAD INJURY 87 0.0036
810 COVID-19 312 0.0036
811 SURGERY 137 0.0036
812 RASH GENERALISED 93 0.0036
813 JAUNDICE 81 0.0036
814 HAEMATEMESIS 73 0.0036
815 UNDERDOSE 198 0.0035
816 RASH MACULAR 89 0.0035
817 CHROMATURIA 64 0.0035
818 DEVICE RELATED INFECTION 45 0.0035
819 PALLOR 69 0.0035
820 MIDDLE INSOMNIA 48 0.0035
821 CHEST DISCOMFORT 265 0.0035
822 RESPIRATORY FAILURE 200 0.0035
823 ANAEMIA 518 0.0035
824 MEMORY IMPAIRMENT 367 0.0035
825 BONE PAIN 158 0.0034
826 TACHYCARDIA 234 0.0034
827 THROAT IRRITATION 112 0.0034
828 ABDOMINAL PAIN LOWER 69 0.0034
829 SUICIDAL IDEATION 247 0.0034
830 EYE SWELLING 95 0.0034
831 BLOOD PRESSURE DECREASED 174 0.0034
832 HYPOTENSION 514 0.0033
833 FEAR 77 0.0032
834 RASH PAPULAR 59 0.0032
835 INCORRECT DOSE ADMINISTERED 442 0.0032
836 THIRST 40 0.0032
837 DEVICE MALFUNCTION 140 0.0032
838 TINNITUS 113 0.0032
839 SOMNOLENCE 495 0.0032
840 CORONARY ARTERY DISEASE 87 0.0032
841 PERIPHERAL COLDNESS 34 0.0032
842 DRUG INTERACTION 395 0.0032
843 ARRHYTHMIA 121 0.0031
844 HOT FLUSH 166 0.0031
845 BLOOD POTASSIUM DECREASED 73 0.0031
846 ACUTE MYOCARDIAL INFARCTION 77 0.0031
847 DEAFNESS 60 0.0031
848 THERAPEUTIC RESPONSE UNEXPECTED 110 0.0030
849 LETHARGY 139 0.0030
850 EYE IRRITATION 110 0.0030
851 SWOLLEN TONGUE 76 0.0030
852 PELVIC PAIN 43 0.0030
853 CHOKING 43 0.0030
854 CYTOMEGALOVIRUS INFECTION 37 0.0030
855 ASCITES 68 0.0030
856 ABASIA 73 0.0030
857 ANOREXIA 38 0.0029
858 BONE MARROW FAILURE 54 0.0029
859 METASTASES TO LIVER 38 0.0029
860 COLD SWEAT 41 0.0029
861 FLUID RETENTION 116 0.0029
862 HYPOAESTHESIA ORAL 34 0.0029
863 DEPRESSED MOOD 113 0.0029
864 NERVOUS SYSTEM DISORDER 76 0.0029
865 ANXIETY 650 0.0028
866 BREAST CANCER FEMALE 67 0.0028
867 HIP FRACTURE 69 0.0028
868 NEUTROPHIL COUNT DECREASED 79 0.0028
869 CHRONIC KIDNEY DISEASE 189 0.0028
870 INJECTION SITE MASS 74 0.0028
871 DISEASE PROGRESSION 225 0.0028
872 ABORTION SPONTANEOUS 90 0.0028
873 CARDIAC DISORDER 207 0.0028
874 ATRIAL FIBRILLATION 207 0.0028
875 PRODUCT DOSE OMISSION ISSUE 299 0.0027
876 DYSURIA 80 0.0027
877 PAIN OF SKIN 58 0.0027
878 HYPOPHAGIA 51 0.0027
879 FLUSHING 231 0.0027
880 MULTI-ORGAN FAILURE 47 0.0027
881 CEREBRAL INFARCTION 53 0.0027
882 MENORRHAGIA 53 0.0027
883 CONSTIPATION 416 0.0027
884 ACUTE KIDNEY INJURY 290 0.0027
885 PLATELET COUNT DECREASED 213 0.0027
886 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 95 0.0027
887 UPPER GASTROINTESTINAL HAEMORRHAGE 36 0.0026
888 CHOLESTASIS 37 0.0026
889 ORTHOSTATIC HYPOTENSION 35 0.0026
890 SKIN EXFOLIATION 150 0.0025
891 URINARY RETENTION 65 0.0025
892 SPEECH DISORDER 106 0.0025
893 HAEMORRHAGE 199 0.0025
894 PRURITUS GENERALISED 55 0.0025
895 EPISTAXIS 149 0.0025
896 OSTEONECROSIS 73 0.0025
897 CIRCULATORY COLLAPSE 36 0.0025
898 CARDIAC FAILURE CONGESTIVE 183 0.0025
899 MOOD ALTERED 53 0.0025
900 BALANCE DISORDER 171 0.0025
901 TREMOR 329 0.0025
902 HEPATIC FAILURE 60 0.0025
903 TOXICITY TO VARIOUS AGENTS 295 0.0024
904 HOSPITALISATION 243 0.0024
905 RESTLESS LEGS SYNDROME 35 0.0024
906 BLOOD TRIGLYCERIDES INCREASED 35 0.0024
907 DYSPHAGIA 171 0.0024
908 PANIC ATTACK 68 0.0024
909 FLATULENCE 101 0.0024
910 RETCHING 38 0.0024
911 PULMONARY HYPERTENSION 40 0.0024
912 INTENTIONAL PRODUCT MISUSE 153 0.0023
913 FOETAL EXPOSURE DURING PREGNANCY 140 0.0023
914 PANCREATITIS ACUTE 39 0.0023
915 CARDIAC FAILURE 142 0.0023
916 DEHYDRATION 240 0.0023
917 POLLAKIURIA 73 0.0023
918 BLINDNESS 68 0.0023
919 VISION BLURRED 231 0.0022
920 THROMBOCYTOPENIA 187 0.0022
921 GASTROINTESTINAL HAEMORRHAGE 162 0.0022
922 HAEMATOMA 48 0.0022
923 DIABETIC KETOACIDOSIS 42 0.0022
924 WRONG TECHNIQUE IN DRUG USAGE PROCESS 80 0.0022
925 AGEUSIA 42 0.0022
926 THROAT TIGHTNESS 45 0.0021
927 MELAENA 38 0.0021
928 PRODUCT DOSE OMISSION 140 0.0021
929 NEEDLE ISSUE 34 0.0021
930 DEVICE ISSUE 115 0.0021
931 HYPONATRAEMIA 89 0.0020
932 LACRIMATION INCREASED 41 0.0020
933 NERVOUSNESS 88 0.0020
934 PNEUMONIA ASPIRATION 37 0.0020
935 HYPOXIA 51 0.0019
936 BLOOD CREATINE PHOSPHOKINASE INCREASED 47 0.0019
937 RENAL INJURY 52 0.0019
938 URINARY INCONTINENCE 44 0.0019
939 RENAL FAILURE ACUTE 80 0.0019
940 TRANSIENT ISCHAEMIC ATTACK 52 0.0019
941 DYSGEUSIA 110 0.0018
942 BLOOD BILIRUBIN INCREASED 40 0.0018
943 SEIZURE 142 0.0018
944 CEREBROVASCULAR ACCIDENT 250 0.0018
945 BLOOD GLUCOSE INCREASED 274 0.0018
946 MENTAL IMPAIRMENT 34 0.0018
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 126 0.0018
948 DRY SKIN 160 0.0018
949 PROSTATE CANCER 130 0.0017
950 APHASIA 42 0.0017
951 MENTAL DISORDER 58 0.0017
952 MULTIPLE SCLEROSIS 65 0.0017
953 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
954 HALLUCINATION 89 0.0016
955 HYPERSOMNIA 35 0.0016
956 HYPERGLYCAEMIA 46 0.0016
957 HAEMATURIA 45 0.0016
958 OSTEONECROSIS OF JAW 34 0.0016
959 DRUG DOSE OMISSION 260 0.0016
960 DYSARTHRIA 46 0.0015
961 DYSKINESIA 48 0.0015
962 OVERDOSE 236 0.0014
963 ACCIDENTAL EXPOSURE TO PRODUCT 71 0.0014
964 RESPIRATORY ARREST 34 0.0014
965 PANCREATIC CARCINOMA 34 0.0014
966 INTERNATIONAL NORMALISED RATIO INCREASED 36 0.0014
967 NIGHTMARE 38 0.0014
968 AGITATION 78 0.0013
969 FEBRILE NEUTROPENIA 59 0.0013
970 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0012
971 VISUAL ACUITY REDUCED 37 0.0012
972 COMA 44 0.0012
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 157 0.0012
974 DISTURBANCE IN ATTENTION 50 0.0012
975 NO ADVERSE EVENT 123 0.0011
976 COGNITIVE DISORDER 40 0.0011
977 BRADYCARDIA 48 0.0011
978 VAGINAL HAEMORRHAGE 41 0.0011
979 DISORIENTATION 37 0.0011
980 PRODUCT STORAGE ERROR 41 0.0011
981 CARDIAC ARREST 72 0.0011
982 HYPOGLYCAEMIA 42 0.0011
983 CONVULSION 58 0.0010
984 THERAPY CESSATION 35 0.0010
985 IRRITABILITY 47 0.0009
986 BLOOD GLUCOSE DECREASED 35 0.0009
987 EMOTIONAL DISTRESS 86 0.0008
988 PRODUCT SUBSTITUTION ISSUE 37 0.0008
989 SKIN BURNING SENSATION 45 0.0008
990 DEATH 476 0.0007
991 BLADDER CANCER 35 0.0007
992 DRUG DEPENDENCE 96 0.0007
993 PRODUCT QUALITY ISSUE 54 0.0005